Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Wiendl, H. (federführend). Diagnostik und Therapie der myasthenia gravis und des Lambert-Eaton Syndroms.
https://www.dgn.org/leitlinien/3005-ll-68-ll-diagnostik-und-therapie-der-myasthenia-gravis-und-des-lambert-eaton-syndroms
. Accessed 22 Mar 2019.
2. Meriggioli, M. N., & Sanders, D. B. (2009). Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity. Lancet Neurology, 8, 475–490.
3. Lacomis, D. (2005). Myasthenic crisis. Neurocritical Care, 3, 189–194.
4. Alshekhlee, A., Miles, J. D., Katirji, B., et al. (2009). Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology, 72, 1548–1554.
5. Thomas, C. E., Mayer, S. A., Gungor, Y., et al. (1997). Myasthenic crisis: Clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology, 48, 1253–1260.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献